Cellular proliferation and angiogenesis in nasal polyps of young adult and geriatric patients

International Forum of Allergy and Rhinology

Volumn 5, Issue 6, 2015, Pages 541-546

  Shin, Jae Min ^a   Byun, Jang Yul ^a   Baek, Byoung Joon ^a   Lee, Jae Yong ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Angiogenesis; Cellular proliferation; Geriatric; Immunohistochemistry; Ki67; Nasal polyp; Proliferating cell nuclear antigen; Surgical outcome; Vascular endothelial growth factor; Young adult

Indexed keywords

CYCLINE; KI 67 ANTIGEN; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CASE CONTROL STUDY; CELL PROLIFERATION; CLINICAL ARTICLE; CROSS REACTION; ENDOSCOPIC SINUS SURGERY; FEMALE; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NOSE POLYP; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT; AGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL PROLIFERATION; HUMANS; KI-67 ANTIGEN; NASAL POLYPS; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTORS; YOUNG ADULT;

EID: 84930473033     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21506     Document Type: Article

References (28)

1. Bernstein JM. Update on the molecular biology of nasal polyposis. Otolaryngol Clin North Am. 2005;38:1243-1255.
2. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol. 1999;28:717-713.
3. Newton JR, Ah-See KW. A review of nasal polyposis. The Clin Risk Manag. 2008;4:507-512.
4. Lee JY, Lee SW. Influence of age on the surgical outcome after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2007;117:1084-1089.
5. Lavezi A, Mantovanni M, Cazzllo A, Turconi P, Matturri L. p53 over-expression and its correlation with PCNA index in nasal polyps. Rhinology. 1999;37:160-163.
6. Welkoborsky HJ, Portmann K, Hoffmann F, Jacob R, Mann WJ, Amedee RG. Proliferative activity and cytometric characteristics in polyps of the nasal cavity and paranasal sinuses. Am J Rhinol. 2000;14:87-91.
7. Coste A, Rateau JG, Roudot-Thoraval F, et al. Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg. 1996;122:432-436.
8. Wittekindt C, Hess A, Bloch W, Sultanie S, Michel O. Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa. Eur Arch Otorhinolaryngol. 2002;259:294-298.
9. Clinical indicators compendium. Am Acad Otolaryngol Bull. 1999;18:32-33.
10. Kosem M, Bulut G, Kaya Z. Analysis of Ki-67 immunoreactivity in recurring and nonrecurring nasal polyps. J Otolaryngol Head Neck Surg. 2010;39:464-467.
11. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope. 1992;102:1-18.
12. Jiang RS, Hsu CY. Functional endoscopic sinus surgery in children and adults. Ann Otol Rhinol Laryngol. 2000;109:1113-1116.
13. McMains KC, Kountakis SE. Revision functional endoscopic sinus surgery: objective and subjective surgical outcomes. Am J Rhinol. 2005;19:344-347.
14. Watelet JB, Annicq B, van Cauwenberge P, Bachert C. Objective outcome after functional endoscopic sinus surgery: prediction factors. Laryngoscope. 2004;114:1092-1097.
15. Ramadan HH. Surgical causes of failure in endoscopic sinus surgery. Laryngoscope. 1999;109:27-29.
16. Wynn R, Har-EI G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. Laryngoscope. 2004;114:811-813.
17. Deal RT, Kountakis SE. Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes. Laryngoscope. 2004;114:1932-1935.
18. Hsu MC, Shn CT, Liu CM. Increased epithelial cell proliferation in nasal polyps. J Formos Med Assoc. 2002;101:227-229.
19. Travali S, Ku D-H, Rizzo MG, Ottavio L, Baserga R, Calabretta B. Structure of the human gene for the proliferative cell nuclear antigen. J Biol Chem. 1989;264:7466-7472.
20. Huisman MA, De Heer E, Grote JJ. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis. Acta Otolaryngol. 2003;123:377-382.
21. Coste A, Rateau JG, Bernaudin JF, Peynegre R, Escudier E. Nasal polyposis pathogenesis: a flow cytometric and immunohistochemical study of epithelial cell proliferation. Acta Otolaryngol. 1996;116:755-761.
22. Tezer I, Celebi Erdivanli O, Sanli A, Aydin S. Could cellular proliferation be a predictive index for the relapse of nasal polyposis and down-regulated by nasal steroid treatment? Indian J Otolaryngol Head Neck Surg. 2013;65:329-332.
23. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
24. Karatzanis AD, Samara KD, Antoniou KM, et al. Investigation of angiogenetic pathways in nasal polyps. Mol Med Rep. 2012;5:1158-1162.
25. Gosepath J, Brieger J, Lehr HA, Mann WJ. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps. Am J Rhinol. 2005;19:7-13.
26. Park SK, Kim HI, Yang YI. Role of vascular endothelial growth factor, angiopoietin 1, and angiopoietin 2 in nasal polyp. Laryngoscope. 2009;119:409-413.
27. Coste A, Brugel L, Maitre B, et al. Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor. Eur Respir J. 2000;15:367-372.
28. Caye-Thomasen P, Larsen K, Tingsqaard P, Tos M. Immunohistochemical demonstration and semi-quantitation of vascular endothelial growth factor in recurrent versus non-recurrent nasal polyps. Acta Otolaryngol. 2004;124:706-711.